Conversion From Twice-Daily Tacrolimus Capsules to Once-Daily Extended-Release Tacrolimus (LCPT): A Phase 2 Trial of Stable Renal Transplant Recipients

BACKGROUND: LCP-Tacro is an extended-release formulation of tacrolimus designed for once-daily dosing. Phase 1 studies demonstrated greater bioavailability to twice-daily tacrolimus capsules and no new safety concerns. METHODS: In this phase 2 study, adult stable kidney transplant patients on tacrol...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaber, A. Osama, Alloway, Rita R., Bodziak, Kenneth, Kaplan, Bruce, Bunnapradist, Suphamai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2013
Materias:
Clinical and Translational Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723088/
https://www.ncbi.nlm.nih.gov/pubmed/23715050
http://dx.doi.org/10.1097/TP.0b013e3182962cc1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723088/
https://www.ncbi.nlm.nih.gov/pubmed/23715050
http://dx.doi.org/10.1097/TP.0b013e3182962cc1

Ejemplares similares